Saskatchewan Health Services Databases
- Web site: http://www.health.gov.sk.ca/
Saskatchewan Health provides health services within a publicly funded health system common to Canada. More than 1 Million residents of the province have been enrolled in the health system and systematic collection of data has been conducted since 1962. Data available from the databases, and the dates collection began for each category, include a population registry (1962), a cancer registry (1967), hospitalization information (1970), medical services data (1971), outpatient prescription drug information (1976), and vital statistics (1979). These databases are a valuable resource for drug utilization review, pharmacoepidemiology, health economic, and other health services research. Access to the databases is allowed through a proposal process that follows criteria and procedures for maintaining confidentiality of individuals and the integrity of the databases.
Risch HA, Howe GR. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study. Am J Epidemiol. 1994 Apr 1;139(7):670-83.
Sharpe CR. Population-based case-control study of the effects of nonsteroidal anti-inflammatory drugs on the risk of breast cancer [dissertation]. Montreal: McGill University. 1999.
Sharpe CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA. Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer. 2000 Jul;83(1):112-20.
Sharpe CR, Collet JP, Belzile E, Hanley JA, Boivin JF. The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer. 2002 Jan 7;86(1):92-7.
Beck P, Wysowski DK, Downey W, Butler-Jones D. Statin use and the risk of breast cancer. J Clin Epidemiol. 2003 Mar;56(3):280-5.
Tamim HM. Population-based case-control study of the effects of antidepressant drugs on the risk of development of cancer [dissertation]. Montreal (PQ): McGill University. 2003.
Csizmadi I, Collet JP, Benedetti A, Boivin JF, Hanley JA. The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women. Br J Cancer. 2004 Jan 12;90(1):76-81.